Epiphany Residential provides drug and alcohol treatment from its location at 100 Masonic Avenue in San Francisco, California. It is a nonprofit provider.
Its services include residential (inpatient) treatment, medication-assisted treatment (MAT), co-occurring (dual diagnosis) mental health treatment, and telehealth therapy. Clinicians use approaches such as anger management, brief intervention, cognitive behavioral therapy, contingency management/motivational incentives, and community reinforcement plus vouchers. For opioid use disorder, the program uses buprenorphine and naltrexone. It also prescribes medication for alcohol use disorder.
Payment options include government funding for substance use treatment, Medicare, Medicaid, and state-financed health insurance plan other than Medicaid. A sliding fee scale based on income is available. Coverage depends on your specific plan, so verify benefits before admission.
The program accepts young adults, adults, and seniors and serves female clients only. It offers specialized groups for pregnant/postpartum women, clients with co-occurring mental and substance use disorders, and clients who have experienced trauma. Sign language services are available for deaf and hard-of-hearing clients.
The facility reports licensing or certification from the state substance use treatment agency and state department of health.
Support services include aftercare/continuing care, discharge planning, naloxone and overdose education, and outcome follow-up after discharge.